Prior to SAS, Greg was Chief Commercial Officer of Castle Creek Biosciences, Inc.. Greg has more than 30 years of industry experience in executive management, sales, market access, marketing, and business development. Previously, Greg served as Chief Executive Officer of Castle Creek Pharmaceuticals. Prior to joining Castle Creek, he managed and developed successful strategies for Zimmer Biomet/ Biologics Division’s first prescription injectable product, Gel-One®. Previously, Greg led the build out of Savient’s biologics arm taking responsibility for Operations, Sales and Managed Care in support of EUFLEXXA®, the company’s first biologic launch. Greg is also a Strategic Advisory Board Member for TCB Capital Advisors. He graduated from Illinois State University with a B.S. in political science
The days of one-size-fits-all messaging in the pharmaceutical industry are fading. Today's patients and health care providers (HCPs) expect personalized content across a variety of channels. This is where generative AI (GenAI) can really help execute cross-channel marketing. Reaching the right audience with the right message Imagine a world where
